Genopathy
Gene-Disorder Association · Article
Gene
CACNA1C
Calcium Voltage-Gated Channel Subunit Alpha1 C
Disorder
Heart Disease
First reported 1950
Key publication · disorder Statistical studies of heart disease; mortality from eight specific forms of heart disease among white persons.Public health reports (Washington, D.C. : 1896) · 1950
Manually curatedApproved treatment annotated
Association Review

In brief

The association between CACNA1C (Calcium Voltage-Gated Channel Subunit Alpha1 C) and Heart Disease is reported, with clinical genetic testing available.

Sources 1
Clinical variants 0
Symptoms 6
Compounds 2
Trials 59of 333 via CACNA1C compounds
Publications 0
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

1 source

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
CACNA1C

The gene

2 source summaries

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Heart Disease

The disorder

18 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
Interventions

Therapeutics

2 compounds & drugs

Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.

Request access
06
Human studies

Clinical trials

333 clinical trials

Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.

Request access
07
Provenance

References & sources

6 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access